Aurobindo Arm CuraTeQ Gets Brazil’s ANVISA GMP Approval for Hyderabad Plant
CuraTeQ Biologics Private Ltd., a wholly owned subsidiary of Aurobindo Pharma Ltd., has received Good Manufacturing Practice (GMP) approval from Brazil’s National Health Surveillance Agency (ANVISA) for its biosimilars manufacturing facility in Hyderabad. According to a stock exchange filing, ANVISA conducted a GMP inspection of the facility from May 11 to May 15, 2026. The […]

